What medications are used to treat colon cancer?

Many gastrointestinal disorders affecting the large intestine present symptoms similar to those of colorectal cancer; thus, patients with such conditions face a significantly higher risk of developing colorectal cancer compared to the general population. Moreover, if chronic colitis remains inadequately controlled, it may also progress to malignancy. Therefore, any disease involving this anatomical region warrants prompt medical evaluation and intervention. So, what medications are used to treat colorectal cancer? The following section addresses this question.

What medications are used to treat colorectal cancer?

Currently, in clinical practice, chemotherapy agents constitute the mainstay of pharmacologic treatment for colorectal cancer. These include oxaliplatin, fluorouracil (5-FU), leucovorin calcium, capecitabine (Xeloda®), and tegafur/gimeracil/oteracil (TS-1®). Such agents are employed either preoperatively—termed neoadjuvant chemotherapy—or postoperatively—termed adjuvant chemotherapy.

Targeted therapies have also become increasingly prevalent in the clinical management of colorectal cancer. The most commonly used agents include bevacizumab and cetuximab. Symptomatic treatments—for instance, loperamide or smectite for frequent diarrhea, or atropine or anisodamine for abdominal pain—may be prescribed as needed. Please note that the above information is for reference only; specific drug selection and administration must be determined by a qualified physician based on individual patient circumstances.

Additionally, for patients with advanced-stage colorectal cancer, treatment must be highly individualized according to the specific clinical features, aiming to maximize survival duration.

We hope the above information proves helpful to you.